Tags » TAVR

Transcatheter Aortic Valve Replacement (TAVR) Expands Options for Inoperable Severe Aortic Stenosis Patients

Surgical aortic valve replacement is extremely low-risk for most patients. However, a significant number of patients are at high-risk for surgical valve replacement or are ineligible for surgery because of comorbidities. 583 more words

Penn State Hershey Heart And Vascular Institute

Top med tech stories from previous day 17/03/2015

Medical device trends brings you top 3 stories from previous day. As these features remained at the forefront in terms of tweets , views and discussions, we bring you quick snapshot of their content. 50 more words

Medical Device Trends : VC Funding

ACC15 Presentations Make Nonsurgical Aortic Valve Replacement Look Very Promising

At the ACC meetings yesterday, several “late-breaking clinical trial” presentations provided substantial reasons to be enthusiastic about transcutaneous aortic valve replacement (TAVR) in comparison to standard surgical AV replacement (SAVR). 403 more words

Valvular Heart Disease

Encouraging Long Term Results For Less Invasive Heart Valves

The publications five years ago of the two part PARTNER trial brought a major change in the treatment options available to some people with aortic valve disease, which is often an extremely serious condition with a poor prognosis.  102 more words

Interventional Cardiology & Surgery

High Risks And Rewards Found With Heart Valve Device From Edwards And Medtronic

Transcatheter aortic valve replacement (TAVR) is one of the most important advances in cardiovascular medicine in recent years. TAVR devices, introduced recently in the US by Edwards Lifesciences and Medtronic, are associated with very high risks, but offer a less invasive alternative to traditional aortic valve replacement surgery. 78 more words

Policy & Ethics

External iliac remote endarterectomy in lieu of a conduit for TEVAR

The patient had diffuse atherosclerosis with small luminal area even in areas without calcified plaque. It predicted inaccessibility for the 22 French sheath required to deliver the 32mm C-TAG device to be placed for a symptomatic type B thoracic aortic dissection associated with a small but expanding proximal aneurysm. 502 more words

Techniques

Genesis: First Hospital to do New Heart Procedure in the Quad Cities

Genesis Health System is the first hospital in the Quad Cities to do a Transcatheter Aortic Valve Replacement, or TAVR.

A TAVR replaces a shrinking heart valve with a man made one. 211 more words

Food And Health